General Description
Orphenadrine Citrate is a centrally acting skeletal muscle relaxant and anticholinergic agent used in the management of acute musculoskeletal pain and as an adjunct in Parkinson's disease therapy. Its chemical structure is related to diphenhydramine with an ortho-methyl substitution on one phenyl ring, conferring both antihistamine and anticholinergic properties. The citrate salt provides enhanced aqueous solubility for oral and parenteral administration.
Mechanism of Action
Orphenadrine Citrate exerts its muscle relaxant and antiparkinsonian effects through multiple mechanisms: central anticholinergic activity blocking muscarinic acetylcholine receptors in the corpus striatum, restoring the balance between dopaminergic and cholinergic transmission that is disrupted in Parkinson's disease; and antihistamine properties contributing to CNS depression and sedation. Its analgesic effect in musculoskeletal conditions is thought to be partially mediated through NMDA receptor antagonism.
Application
Orphenadrine Citrate is indicated for the symptomatic relief of acute, painful musculoskeletal conditions such as muscle strains, sprains, and associated muscle spasms, as well as for the management of tremor, rigidity, and bradykinesia in Parkinson's disease and drug-induced extrapyramidal symptoms.